β1,4-Galactosyltransferase V regulates self-renewal of glioma-initiating cell

Biochemical and Biophysical Research Communications

Volumn 396, Issue 3, 2010, Pages 602-607

  Wei, Yuanyan ^a   Zhou, Fengbiao ^a   Ge, Yuqing ^a   Chen, Hong ^a   Cui, Chunhong ^a   Li, Qiuping ^b   Liu, Dan ^a   Yang, Zhiyuan ^a   Wu, Guoqiang ^a   Sun, Shuhui ^c   Gu, Jianxin ^a   Jiang, Jianhai ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

1,4 Galactosyltransferase V; Glioma; Self renewal; Stem cell; Tumorigenicity

Indexed keywords

BETA1,4 GALACTOSYLTRANSFERASE V; CD133 ANTIGEN; GALACTOSYLTRANSFERASE; UNCLASSIFIED DRUG; AMINOSUGAR; BETA 1,4 GALACTOSYLTRANSFERASE V; BETA-1,4-GALACTOSYLTRANSFERASE V; POLYLACTOSAMINE; POLYSACCHARIDE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOGENICITY; CELL ACTIVITY; CELL RENEWAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA INTERFERENCE; ANIMAL; CANCER STEM CELL; DRUG SCREENING; ENZYMOLOGY; GENE SILENCING; GENETICS; GLIOMA; METABOLISM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

AMINO SUGARS; ANIMALS; CELL LINE, TUMOR; GALACTOSYLTRANSFERASES; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS; MICE; MICE, NUDE; NEOPLASTIC STEM CELLS; POLYSACCHARIDES; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953232420     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.110     Document Type: Article

References (46)

1. Demuth T., and Berens M.E. Molecular mechanisms of glioma cell migration and invasion. J. Neurooncol. 70 (2004) 217-228
2. Tonn J.C., and Goldbrunner R. Mechanisms of glioma cell invasion. Acta Neurochir. Suppl. 88 (2003) 163-167
3. Dick J.E. Stem cell concepts renew cancer research. Blood 112 (2008) 4793-4807
4. Cabanillas R., and Llorente J.L. The Stem Cell Network model: clinical implications in cancer. Eur. Arch. Otorhinolaryngol. 266 (2009) 161-170
5. Clark A.T. The stem cell identity of testicular cancer. Stem Cell Rev. 3 (2007) 49-59
6. Glinsky G.V. Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers. Stem Cell Rev. 3 (2007) 79-93
7. Zhou Z.H., Ping Y.F., Yu S.C., Yi L., Yao X.H., Chen J.H., Cui Y.H., and Bian X.W. A novel approach to the identification and enrichment of cancer stem cells from a cultured human glioma cell line. Cancer Lett. 281 (2009) 92-99
8. Marumoto T., Tashiro A., Friedmann-Morvinski D., Scadeng M., Soda Y., Gage F.H., and Verma I.M. Development of a novel mouse glioma model using lentiviral vectors. Nat. Med. 15 (2009) 110-116
9. Alcantara Llaguno S., Chen J., Kwon C.H., Jackson E.L., Li Y., Burns D.K., Alvarez-Buylla A., and Parada L.F. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15 (2009) 45-56
10. Zheng H., Ying H., Yan H., Kimmelman A.C., Hiller D.J., Chen A.J., Perry S.R., Tonon G., Chu G.C., Ding Z., Stommel J.M., Dunn K.L., Wiedemeyer R., You M.J., Brennan C., Wang Y.A., Ligon K.L., Wong W.H., Chin L., and DePinho R.A. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 455 (2008) 1129-1133
11. Du Z., Jia D., Liu S., Wang F., Li G., Zhang Y., Cao X., Ling E.A., and Hao A. Oct4 is expressed in human gliomas and promotes colony formation in glioma cells. Glia 57 (2009) 724-733
12. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., and Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39 (2002) 193-206
13. Rhee W., Ray S., Yokoo H., Hoane M.E., Lee C.C., Mikheev A.M., Horner P.J., and Rostomily R.C. Quantitative analysis of mitotic Olig2 cells in adult human brain and gliomas: implications for glioma histogenesis and biology. Glia 57 (2009) 510-523
14. Fine H.A. Glioma stem cells: not all created equal. Cancer Cell 15 (2009) 247-249
15. Stiles C.D., and Rowitch D.H. Glioma stem cells: a midterm exam. Neuron 58 (2008) 832-846
16. Das S., Srikanth M., and Kessler J.A. Cancer stem cells and glioma. Nat. Clin. Pract. Neurol. 4 (2008) 427-435
17. Griffero F., Daga A., Marubbi D., Capra M.C., Melotti A., Pattarozzi A., Gatti M., Bajetto A., Porcile C., Barbieri F., Favoni R.E., Lo Casto M., Zona G., Spaziante R., Florio T., and Corte G. Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. J. Biol. Chem. 284 (2009) 7138-7148
18. Couldrey C., and Green J.E. Metastases: the glycan connection. Breast Cancer Res. 2 (2000) 321-323
19. Rebbaa A., Yamamoto H., Saito T., Meuillet E., Kim P., Kersey D.S., Bremer E.G., Taniguchi N., and Moskal J.R. Gene transfection-mediated overexpression of beta1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function. J. Biol. Chem. 272 (1997) 9275-9279
20. Yamamoto H., Swoger J., Greene S., Saito T., Hurh J., Sweeley C., Leestma J., Mkrdichian E., Cerullo L., Nishikawa A., Ihara Y., Taniguchi N., and Moskal J.R. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity. Cancer Res. 60 (2000) 134-142
21. Lo N.W., Shaper J.H., Pevsner J., and Shaper N.L. The expanding beta 4-galactosyltransferase gene family: messages from the databanks. Glycobiology 8 (1998) 517-526
22. Sato T., and Furukawa K. Sequential action of Ets-1 and Sp1 in the activation of the human beta-1,4-galactosyltransferase V gene involved in abnormal glycosylation characteristic of cancer cells. J. Biol. Chem. 282 (2007) 27702-27712
23. Sato T., Furukawa K., Bakker H., Van den Eijnden D.H., and Van Die I. Molecular cloning of a human cDNA encoding beta-1,4-galactosyltransferase with 37% identity to mammalian UDP-Gal:GlcNAc beta-1,4-galactosyltransferase. Proc. Natl. Acad. Sci. USA 95 (1998) 472-477
24. Sato T., Guo S., and Furukawa K. Occurrence of poly-N-acetyllactosamine synthesis in Sf-9 cells upon transfection of individual human beta-1,4-galactosyltransferase I, II, III, IV, V and VI cDNAs. Biochimie 83 (2001) 719-725
25. Sato T., Shirane K., Kido M., and Furukawa K. Correlated gene expression between beta-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines. Biochem. Biophys. Res. Commun. 276 (2000) 1019-1023
26. Xu S., Zhu X., Zhang S., Yin S., Zhou L., Chen C., and Gu J. Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma. J. Cancer Res. Clin. Oncol. 127 (2001) 502-506
27. Jiang J., Wei Y., Shen J., Liu D., Chen X., Zhou J., Zong H., Yun X., Kong X., Zhang S., Yang Y., and Gu J. Functional interaction of E1AF and Sp1 in glioma invasion. Mol. Cell. Biol. 27 (2007) 8770-8782
28. Jiang J., Chen X., Shen J., Wei Y., Wu T., Yang Y., Wang H., Zong H., Yang J., Zhang S., Xie J., Kong X., Liu W., and Gu J. Beta1,4-galactosyltransferase V functions as a positive growth regulator in glioma. J. Biol. Chem. 281 (2006) 9482-9489
29. Sato T., and Furukawa K. Transcriptional regulation of the human beta-1,4-galactosyltransferase V gene in cancer cells: essential role of transcription factor Sp1. J. Biol. Chem. 279 (2004) 39574-39583
30. Xu S., Zhang S., Chen C., Yan J., Cai M., Zhu X., and Gu J. Over-expression of beta-1,4-galactosyltransferase V increases the growth of astrocytoma cell line. J. Exp. Clin. Cancer Res. 21 (2002) 409-414
31. Wei Y., Liu D., Ge Y., Zhou F., Xu J., Chen H., Yun X., Gu J., and Jiang J. Down-regulation of beta1,4GalT V at protein level contributes to arsenic trioxide-induced glioma cell apoptosis. Cancer Lett. 267 (2008) 96-105
32. Ishida H., Togayachi A., Sakai T., Iwai T., Hiruma T., Sato T., Okubo R., Inaba N., Kudo T., Gotoh M., Shoda J., Tanaka N., and Narimatsu H. A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer. FEBS Lett. 579 (2005) 71-78
33. Cheng J.X., Liu B.L., and Zhang X. How powerful is CD133 as a cancer stem cell marker in brain tumors. Cancer Treat. Rev. 35 (2009) 403-408
34. Kondo T. Stem cell-like cancer cells in cancer cell lines. Cancer Biomark. 3 (2007) 245-250
35. Nakano I., Saigusa K., and Kornblum H.I. BMPing off glioma stem cells. Cancer Cell 13 (2008) 3-4
36. Kobayashi N., Navarro-Alvarez N., Soto-Gutierrez A., Kawamoto H., Kondo Y., Yamatsuji T., Shirakawa Y., Naomoto Y., and Tanaka N. Cancer stem cell research: current situation and problems. Cell Transplant. 17 (2008) 19-25
37. Klonisch T., Wiechec E., Hombach-Klonisch S., Ande S.R., Wesselborg S., Schulze-Osthoff K., and Los M. Cancer stem cell markers in common cancers - therapeutic implications. Trends Mol. Med. 14 (2008) 450-460
38. Hambardzumyan D., Squatrito M., Carbajal E., and Holland E.C. Glioma formation, cancer stem cells, and akt signaling. Stem Cell Rev. 4 (2008) 203-210
39. Sell S. Cancer and stem cell signaling: a guide to preventive and therapeutic strategies for cancer stem cells. Stem Cell Rev. 3 (2007) 1-6
40. Wu A., Oh S., Wiesner S.M., Ericson K., Chen L., Hall W.A., Champoux P.E., Low W.C., and Ohlfest J.R. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. Stem Cells Dev. 17 (2008) 173-184
41. Kang M.K., and Kang S.K. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev. 16 (2007) 837-847
42. Veeravagu A., Bababeygy S.R., Kalani M.Y., Hou L.C., and Tse V. The cancer stem cell-vascular niche complex in brain tumor formation. Stem Cells Dev. 17 (2008) 859-867
43. Fan X., Salford L.G., and Widegren B. Glioma stem cells: evidence and limitation. Semin. Cancer Biol. 17 (2007) 214-218
44. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., and Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
45. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56 (1996) 5309-5318
46. Dawson G., Moskal J.R., and Dawson S.A. Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death. J. Neurochem. 89 (2004) 1436-1444